IFP Advisors, Inc - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,602
-69.6%
73
-50.0%
0.00%
Q2 2023$8,546
+65.0%
146
+100.0%
0.00%
Q1 2023$5,179
+32268.8%
73
-68.0%
0.00%
Q4 2022$16
-99.8%
228
+60.6%
0.00%
Q3 2022$10,0000.0%1420.0%0.00%
Q2 2022$10,0000.0%1420.0%0.00%
Q1 2022$10,000142
+3450.0%
0.00%
Q2 2021$0
-100.0%
4
-71.4%
0.00%
Q1 2021$2,000
-50.0%
14
-56.2%
0.00%
Q4 2020$4,000
+300.0%
32
+220.0%
0.00%
Q3 2020$1,000100.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2018$1,0000.0%140.0%0.00%
Q2 2018$1,00014
+250.0%
0.00%
Q3 2017$040.0%0.00%
Q2 2017$040.0%0.00%
Q1 2017$040.0%0.00%
Q4 2016$040.0%0.00%
Q3 2016$040.0%0.00%
Q2 2016$0
-100.0%
4
-63.6%
0.00%
Q4 2015$1,000110.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2018
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders